CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

featured-image

CytoSorbents Corp (CTSO) reports a 25% increase in Q4 product revenue and outlines plans for a major product launch amidst financial improvements and challenges.

CytoSorbents Corp (CTSO) reports a 25% increase in Q4 product revenue and outlines plans for a major product launch amidst financial improvements and challenges..